<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Crit Care</journal-id><journal-id journal-id-type="iso-abbrev">Crit Care</journal-id><journal-title-group><journal-title>Critical Care</journal-title></journal-title-group><issn pub-type="ppub">1364-8535</issn><issn pub-type="epub">1466-609X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">3642592</article-id><article-id pub-id-type="publisher-id">cc12187</article-id><article-id pub-id-type="doi">10.1186/cc12187</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Clinical effect of altered lipid emulsion composition containing fish oil in postoperative patients following abdominal surgery: a prospective, randomized, open-label, comparative, multicenter phase 3 clinical study</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Keum</surname><given-names>M</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A2"><name><surname>Hong</surname><given-names>S</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Han</surname><given-names>H</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Yoon</surname><given-names>D</given-names></name><xref ref-type="aff" rid="I3">3</xref></contrib><contrib contrib-type="author" id="A5"><name><surname>Seo</surname><given-names>J</given-names></name><xref ref-type="aff" rid="I4">4</xref></contrib><contrib contrib-type="author" id="A6"><name><surname>Yun</surname><given-names>I</given-names></name><xref ref-type="aff" rid="I5">5</xref></contrib></contrib-group><aff id="I1"><label>1</label>Asan Medical Center, Seoul, South Korea</aff><aff id="I2"><label>2</label>Seoul National University Bundang Hospital, Seongnam, South Korea</aff><aff id="I3"><label>3</label>Gangnam Severance Hospital, Seoul, South Korea</aff><aff id="I4"><label>4</label>Samsung Medical Center, Seoul, South Korea</aff><aff id="I5"><label>5</label>Konkuk University Medical Center, Seoul, South Korea</aff><pub-date pub-type="ppub"><year>2013</year></pub-date><pub-date pub-type="epub"><day>19</day><month>3</month><year>2013</year></pub-date><volume>17</volume><issue>Suppl 2</issue><supplement><named-content content-type="supplement-title">33rd International Symposium on Intensive Care and Emergency Medicine</named-content><named-content content-type="supplement-sponsor">Publication of this supplement was supported by ISICEM</named-content></supplement><fpage>P249</fpage><lpage>P249</lpage><permissions><copyright-statement>Copyright &#x000a9; 2013 Keum et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Keum et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://ccforum.com/content/17/S2/P249"/><conference><conf-date>19-22 March 2013</conf-date><conf-name>33rd International Symposium on Intensive Care and Emergency Medicine</conf-name><conf-loc>Brussels, Belgium</conf-loc></conference></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Omega-3 fatty acids have been shown to decrease inflammatory responses after trauma and surgery resulting in reduction of morbidity and mortality in postoperative patients. The n-6:n-3 polyunsaturated fatty acid (PUFA) ratio in parenteral nutrition (PN) also influences the immune modulation. The aim of this study was to evaluate the optimal ratio of PUFA in postoperative patients following abdominal surgery.</p></sec><sec sec-type="methods"><title>Methods</title><p>In a prospective, randomized, open-label, comparative, multicenter, phase 3 clinical study, we compared the safety and efficacy of a 2.1:1 ratio of n-6:n-3 fatty acid compared with 2.5:1 in postoperative patients requiring PN. Fifty-four patients were assigned to receive PN with Combiflex Omega peripheral<sup>&#x000ae; </sup>(CFO, low ratio group, <italic>n = </italic>28) or SMOFKabiven peripheral<sup>&#x000ae; </sup>(KAB, high ratio group, <italic>n = </italic>26) for 3 days after abdominal surgery. Safety and efficacy were monitored daily with laboratory parameters, vital signs, and adverse events from the operation day (day 0) until the end of the study (day 4).</p></sec><sec sec-type="results"><title>Results</title><p>Total cholesterol (TC) and low-density lipoprotein-cholesterol (LDL-C) levels were less changed significantly in the low ratio group (3 &#x000b1; 18 vs. 16 &#x000b1; 23 mg/dl, <italic>P </italic>= 0.027 for TC, 4 &#x000b1; 12 vs. 12 &#x000b1; 18 mg/dl, <italic>P </italic>= 0.026 for LDL-C) compared with the high ratio group in postoperative patients. Other laboratory parameters and adverse events did not show statistically significant differences between the groups. See Table <xref ref-type="table" rid="T1">1</xref>.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Lipid emulsion composition of CFO and KAB</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th align="center">CFO</th><th align="center">KAB</th></tr></thead><tbody><tr><td align="left">LCT (g/l)</td><td align="center">60</td><td align="center">60</td></tr><tr><td align="left">MCT (g/l)</td><td align="center">50</td><td align="center">60</td></tr><tr><td align="left">Olive oil (g/l)</td><td align="center">50</td><td align="center">50</td></tr><tr><td align="left">Fish oil (g/l)</td><td align="center">40</td><td align="center">30</td></tr><tr><td align="left">n-6:n-3</td><td align="center">2.1:1</td><td align="center">2.5:1</td></tr></tbody></table></table-wrap></sec><sec sec-type="conclusions"><title>Conclusion</title><p>CFO containing low n-6:n-3 PUFA ratio was comparable with KAB in safety and efficacy in postoperative patients requiring PN and also had advantages with regard to lipid metabolism aspect.</p></sec></body><back><ref-list><ref id="B1"><mixed-citation publication-type="other"><name><surname>Simopoulos</surname><given-names>AP</given-names></name><source>Biomed Pharmacother</source><year>2002</year><volume>56</volume><fpage>365</fpage><lpage>379</lpage><pub-id pub-id-type="doi">10.1016/S0753-3322(02)00253-6</pub-id><pub-id pub-id-type="pmid">12442909</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="other"><name><surname>Heller</surname><given-names>AR</given-names></name><etal/><source>Crit Care Med</source><year>2006</year><volume>34</volume><fpage>972</fpage><lpage>979</lpage><pub-id pub-id-type="doi">10.1097/01.CCM.0000206309.83570.45</pub-id><pub-id pub-id-type="pmid">16484909</pub-id></mixed-citation></ref></ref-list></back></article>